Jecheskiel Gonczarowski

Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.

Getter Group Ltd. engages in the representation of international brands in Israel and abroad. Its services include marketing, distribution, and provision of support services for products and solutions in the fields of printing, medical equipment, electronics, communication, infrastructure, computers, toys, photography, and transportation equipment. The company was founded by Jecheskiel Gonczarowski in 1955 and is headquartered in Petach-Tikva, Israel.